Philip K Hsieh

Title: The Innovations of Philip K. Hsieh

Introduction

Philip K. Hsieh is a notable inventor based in Thousand Oaks, California. He has made significant contributions to the field of biotechnology, particularly in the production of biologically active insulin-like growth factor I (IGF-I). His innovative methods have the potential to impact various medical applications.

Latest Patents

Hsieh holds a patent for a novel method for refolding reduced IGF-I. This method involves providing additional positive charge at the amino terminal end of the IGF-I molecule through a short leader sequence. The presence of this additional positive charge enables recombinant IGF-I to refold simply by stirring solubilized inclusion body protein for a duration of 2 to 16 hours, or even overnight. This innovative approach enhances the efficiency of producing biologically active IGF-I.

Career Highlights

Hsieh is associated with Amgen Inc., a leading biotechnology company known for its focus on innovative therapies. His work at Amgen has allowed him to contribute to advancements in the field of protein production and therapeutic development.

Collaborations

Throughout his career, Hsieh has collaborated with esteemed colleagues, including James A. Miller and Larry B. Tsai. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Philip K. Hsieh's contributions to biotechnology, particularly in the production of insulin-like growth factor I, highlight his role as an influential inventor. His innovative methods and collaborations continue to pave the way for advancements in medical science.